Press Release:

Total Artificial Heart recipient Bill Wohl and his partner Jane Tucker promote organ donation awareness worldwide. In April 2009, Wohl was one of the recipients recognized at the Arizona State Capitol to celebrate Donor Awareness month. Wohl will celebrate 10 years of life with his donor heart on Feb. 22, 2010.

TUCSON, Ariz. – Feb. 16, 2010 – On Feb. 22, Bill Wohl, a former recipient of the SynCardia temporary CardioWest™ Total Artificial Heart, will celebrate 10 years of enjoying life to the fullest with the donor heart he received at University Medical Center on Feb. 22, 2000.  

“It’s pretty amazing,” said Wohl. “If it wasn’t for the SynCardia Total Artificial Heart and my transplant, my son and daughter wouldn’t have a father and I wouldn’t be here to enjoy them.”

On Easter Sunday 1999, Wohl went to the emergency room for what he thought was food poisoning, but doctors discovered he had suffered a massive heart attack. Wohl was told he needed a heart transplant, but was too sick to receive one. Over the next six months, Wohl was hospitalized 17 times. Then, on Sept. 13, 1999, Wohl’s organs began to shut down. To save his life, doctors implanted the Total Artificial Heart. 

Bill Wohl presents his first two of three gold medals to his heart donor's parents, Stan and Paula Brady, at the N.K.F. U.S. Transplant Games in August 2008 in Pittsburgh.

“I am so blessed to have survived in 1999,” said Wohl. “It took a month after I received the Total Artificial Heart at University Medical Center for me to wake up from a coma. Rich Smith, Director of the Artificial Heart Program, told me I was the worst cardiac case in the hospital’s history.”

Wohl credits his “Triangle Theory” for helping him become healthy enough to receive his donor heart after 159 days with the Total Artificial Heart.

“Patients need to sleep better, eat better and exercise more,” said Wohl “I was only scheduled to go to cardiac rehab once or twice a week, but by the end of my hospital stay, I was begging to go down there six or seven times a week. Exercise helped make my body stronger and better prepared for my transplant.”

Today, Wohl is a decorated transplant games athlete who competes monthly in swimming, cycling and running. In 2008, he had the special opportunity to spend a week with his heart donor’s parents, Stan and Paula Brady, at the U.S. Transplant Games in Pittsburgh. He presented each of them with a gold medal he won during the week.

“It meant so much to me,” said Wohl. “It was one of my proudest moments. If I were scripting a movie, I couldn’t have written it any better.”

Another of Wohl’s accomplishments is helping establish specialty license plates for organ donation in the state of Arizona. In 2002, Wohl brought up the idea during a transplant foundation meeting in Phoenix and fellow Total Artificial Heart and transplant recipient Leo Corbet helped make it a reality. According to the Arizona Department of Transportation, as of Dec. 31, 2009, there were 4,693 Donate Life plates registered in the state of Arizona. The Arizona Coalition for Transplantation receives $17 of each $25 plate purchase and renewal.

“I’ve been able to help people and make a difference with my second chance at life,” said Wohl. “I think that’s why I’m still around today.”

###

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, SynCardia's Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 950 implants of the Total Artificial Heart, accounting for more than 230 patient years of life.

Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers and does not require expensive anti-rejection medication, which can cause subsequent complications. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through both ventricles. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

SynCardia Ranked #20 Among World's 50 Most Innovative Companies
In March 2011, Fast Company magazine ranked SynCardia #20 in its annual list of the "World's 50 Most Innovative Companies" for "giving mobility to artificial heart recipients." Weighing 13.5 pounds, SynCardia's Freedom® portable driver is the world's first wearable driver designed to power the Total Artificial Heart both inside and outside the hospital. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

For additional information, please visit: http://www.syncardia.com
Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn

Media Contact:
Don Isaacs
Vice President of Communications
SynCardia Systems, Inc.
Cell: (520) 955-0660